GLP-1 weight loss medication shortages have been widespread since 2023, driven by unprecedented demand for Ozempic and Wegovy. Novo Nordisk and Eli Lilly have struggled to meet UK supply, affecting both diabetes patients and those prescribed these drugs for weight management.
Current Active Shortages (1)
Mounjaro KwikPen 15mg pre-filled pens
Critical NHSBSA SSPA falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 an
What to Do If Affected
- Contact your prescribing clinic immediately if supply is disrupted
- Do NOT buy GLP-1 medications from unregulated online sources
- Ask your GP about alternative weight management medications
- Diabetes patients on GLP-1s take priority over weight-loss patients — speak to your GP
- Report suspected counterfeit medications to MHRA Yellow Card
Related Medicine Pages
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
Page last updated: 27 March 2026. Data checked daily.
Page last updated: 27 March 2026. Data checked daily.